Spectrum Science Acquires Continuum Clinical

February 8, 2024

Spectrum Science has acquired Continuum Clinical from Blue Chip Worldwide to strengthen its clinical trial recruitment (CTR) capabilities. Continuum will merge into Spectrum’s CTR strategic pillar—bringing its MERIS technology, a large client roster, and leadership under Neil Weisman—creating a combined team of more than 130 clinical solutions specialists; financial terms were not disclosed.

Buyers
Spectrum Science
Targets
Continuum Clinical
Sellers
Blue Chip Worldwide
Location
Illinois, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.